„”
Dr.
Sociality shapes mitochondrial adaptations supporting hypoxia tolerance
Proteome-scale recombinant standards and a robust high-speed search engine to advance cross-linking MS-based interactomics
Nature Methods 2024
read onlineMolecular architecture of synaptic vesicles
Proceedings of the National Academy of Sciences 2024
read onlineRedesigning error control in cross-linking mass spectrometry enables more robust and sensitive protein-protein interaction studies
Molecular Systems Biology 2024
read onlineCross-link assisted spatial proteomics to map sub-organelle proteomes and membrane protein topologies
Nature Communications 2024
read onlineExtensive protein pyrophosphorylation revealed in human cell lines
Nature Chemical Biology 2024
read onlineNucleoside diphosphate kinase A (NME1) catalyzes its own oligophosphorylation
Lysis buffer selection guidance for mass spectrometry-based global proteomics including studies on the intersection of signal transduction and metabolism
Proteome-wide quantification of inositol pyrophosphate-protein interactions
Real-Time Library Search Increases Cross-Link Identification Depth across All Levels of Sample Complexity
Analytical Chemistry 2023
read onlineEnhancing Inter-link Coverage in Cross-Linking Mass Spectrometry through Context-Sensitive Subgrouping and Decoy Fusion
Optimized TMT-Based Quantitative Cross-Linking Mass Spectrometry Strategy for Large-Scale Interactomic Studies
Analytical Chemistry 2022
read onlineAn Unusual Aspartic Acid Cluster in the Reovirus Attachment Fiber σ1 Mediates Stability at Low pH and Preserves Trimeric Organization
Journal of Virology 2022
read onlineThe Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), which legally represents seven non-university research institutes - members of the Leibniz Association - in Berlin.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10,
13125 Berlin, Germany